GSK 3515864: A Phase 3b, multicenter, single-arm, open-label study evaluating the efficacy, safety, and tolerability of switching to DTG/3TC single tablet regimen administered once daily from a bictegravir/emtricitabine/tenofovir alafenamide single table
10/23/2023 - 10/23/2028 (PI)
ViiV Healthcare

GS-US-563-6041: A Phase 2 Randomized, Open-Label, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of Islatravir in Combination with Lenacapavir in Virologically Suppressed People with HIV
04/06/2023 - 12/31/2027 (PI)
Gilead Sciences

GS-US-380-6738: A Phase 4 Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Oral B/F/TAF after Discontinuing Injectable CAB + RPV
12/01/2023 - 12/01/2027 (PI)
Gilead Sciences

TH-IBA-CTR-1003 PROMISE-US
10/27/2022 - 10/27/2025 (PI)
THERATECHNOLOGIES U.S., INC.

Gamma delta T cells promote inflammation in aviremic HIV infection and normal aging
08/15/2020 - 05/31/2025 (PI)
Trustees of Boston University, BUMC National Institute o
5R01AG065050-03

Identifying Factors to Improve Dental and Mental Healthcare among People with HIV
09/22/2023 - 09/21/2024 (PI)
Rhode Island Hospital National Institute o
1R56DE032873-01

Launching a geriatrics and HIV-ID integrated clinic to improve care for people aging with HIV: The HIVE program
08/01/2022 - 07/31/2024 (PI)
Health Resources and Services Administration/DHHS

Solar GSK213500: A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine administer
01/25/2021 - 01/24/2024 (PI)
GlaxoSmithKline

Is Integrase Inhibitor Emergent Weight Gain associated with increased Cardiometabolic Risk? A Nationwide Cohort Analysis
01/24/2022 - 01/23/2024 (PI)
Gilead Sciences

Real-world Clinical Insights and Inflammatory Mechanisms of Integrase Strand Transfer Inhibitor Associated Excessive Weight Gain
07/01/2021 - 12/30/2023 (PI)
The Miriam Hospital National Institute o

1. Pihl RMF, Smith-Mahoney EL, Olson A, Yuen RR, Asundi A, Lin N, Belkina AC, Snyder-Cappione JE. Vd1 Effector and Vd2 ?d T-Cell Subsets Shift in Frequency and Are Linked to Plasma Inflammatory Markers During Antiretroviral Therapy-Suppressed HIV Infection. J Infect Dis. 2024 May 15; 229(5):1317-1327.View Related Profiles.

   Belkina, Anna
   Asundi, Archana
   Snyder-Cappione , Jennifer
   Pihl, Riley
   

   PMID: 38390982; PMCID: PMC11095541; DOI: 10.1093/infdis/jiae091;
2. Lilie T, Bouzy J, Asundi A, Taylor J, Roche S, Olson A, Coxen K, Corry H, Jordan H, Clayton K, Lin N, Tsibris A. Opioid use does not limit potent low-dose HIV-1 latency reversal agent boosting. medRxiv. 2023 Jun 03. PMID: 37398278; PMCID: PMC10312897; DOI: 10.1101/2023.05.26.23290576;
3. Asundi A, Olson A, Jiang W, Varshney SP, White LF, Sagar M, Lin NH. Integrase Inhibitor Use Associated with Weight Gain in Women and Incident Diabetes Mellitus. AIDS Res Hum Retroviruses. 2022 03; 38(3):208-215.View Related Profiles.

   Olson, Alex
   Asundi, Archana
   White, Laura
   Sagar, Manish
   Lin, Nina
   

   PMID: 34877881; PMCID: PMC8968841; DOI: 10.1089/aid.2021.0091;
4. Asundi A, O'Leary C, Bhadelia N. Global COVID-19 vaccine inequity: The scope, the impact, and the challenges. Cell Host Microbe. 2021 07 14; 29(7):1036-1039.View Related Profiles.

   Asundi, Archana
   Bhadelia, Nahid
   

   PMID: 34265241; PMCID: PMC8279498; DOI: 10.1016/j.chom.2021.06.007;
5. Asundi A, Resnik J, Benedict PA, Shin M, Rani Elwy A, Branch-Elliman W. How Are Emerging Data Translated Into Clinical Practice? A Mixed Methods Investigation of Coronavirus Disease 2019 Institutional Treatment Protocols. Open Forum Infect Dis. 2021 Apr; 8(4):ofab072.View Related Profiles.

   Asundi, Archana
   Branch-Elliman, Westyn
   

   PMID: 33855102; PMCID: PMC8026152; DOI: 10.1093/ofid/ofab072;
6. Asundi A, Stanislawski M, Mehta P, Mull HJ, Schweizer ML, Barón AE, Ho PM, Gupta K, Branch-Elliman W. Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program. Sci Rep. 2020 03 24; 10(1):5276.View Related Profiles.

   Asundi, Archana
   Mull, Hillary
   Gupta, Kalpana
   Branch-Elliman, Westyn
   

   PMID: 32210289; PMCID: PMC7093485; DOI: 10.1038/s41598-020-62083-y;
7. Mull HJ, Stolzmann K, Kalver E, Shin MH, Schweizer ML, Asundi A, Mehta P, Stanislawski M, Branch-Elliman W. Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record. BMC Med Inform Decis Mak. 2020 01 30; 20(1):15.View Related Profiles.

   Asundi, Archana
   Mull, Hillary
   Branch-Elliman, Westyn
   

   PMID: 32000780; PMCID: PMC6993312; DOI: 10.1186/s12911-020-1031-5;
8. Asundi A, Bhadelia N. Making Emergency Use of Experimental Vaccines Safer. AMA J Ethics. 2020 01 01; 22(1):E43-49.View Related Profiles.

   Asundi, Archana
   Bhadelia, Nahid
   

   PMID: 31958390
9. Asundi A, Cervantes-Arslanian AM, Lin NH, Barbosa F. Infectious Myelitis. Semin Neurol. 2019 08; 39(4):472-481.View Related Profiles.

   Cervantes-Arslanian, Anna
   Asundi, Archana
   Lin, Nina
   

   PMID: 31533188
10. Asundi A, Robles Y, Starr T, Landay A, Kinslow J, Ladner J, White L, Plank RM, Melbourne K, Weisholtz D, Bennett M, Pan H, Stern E, Lin A, Kuritzkes DR, Lin NH. Immunological and Neurometabolite Changes Associated With Switch From Efavirenz to an Integrase Inhibitor. J Acquir Immune Defic Syndr. 2019 08 15; 81(5):585-593.View Related Profiles.

    Asundi, Archana
    White, Laura
    Lin, Nina
    

    PMID: 31045650; PMCID: PMC6625862; DOI: 10.1097/QAI.0000000000002079;

Showing 10 of 14 results. Show More

Flurry of New Research Explores Weight Gain on Integrase Inhibitors Among People Living With HIV